The Wnt signaling pathway is essential for embryonic development and carcinogenesis. Upon Wnt stimulation, b-catenin is stabilized and associates with T-cell factor or lymphoid enhancing factor, thereby activating transcription of target genes. In the absence of Wnt stimulation, the level of b-catenin is reduced via glycogen synthase kinase (GSK)-3b-mediated phosphorylation and subsequent proteasome-dependent degradation. Here, we report the identification of Ajuba as a negative regulator of the Wnt signaling pathway. Ajuba is a member of LIM domain-containing proteins that contribute to cell fate determination and regulate cell proliferation and differentiation. We found that enforced expression of Ajuba destabilized b-catenin and suppressed target gene expression. Ajuba promoted GSK-3b-mediated phosphorylation of b-catenin by reinforcing the association between b-catenin and GSK-3b. Furthermore, Wnt stimulation induced both accumulation of b-catenin and destabilization of Ajuba. Our findings suggest that Ajuba is important for regulation of the Wnt signaling pathway.
Introduction
The Wnt family of secreted proteins is conserved among species from Caenorhabditis elegans to human and plays important roles in developmental processes by activating transcription of target genes that regulate cell proliferation and differentiation (Miller and Moon, 1996; Cadigan and Nusse, 1997; Bienz and Clevers, 2000; Peifer and Polakis, 2000; Giles et al., 2003) . Deregulation of the Wnt signaling pathway associates with development of various types of tumors (Miller and Moon, 1996; Cadigan and Nusse, 1997; Bienz and Clevers, 2000; Peifer and Polakis, 2000; Giles et al., 2003) . Regulation of the b-catenin level is a critical step in Wnt signaling. In the absence of Wnt stimulation, b-catenin is recruited to a multiprotein complex containing adenomatous polyposis coli (APC) tumor suppressor protein, Axin and glycogen synthase kinase (GSK)-3b. b-Catenin is phosphorylated by GSK-3b and then degraded through the ubiquitin-proteasome system (Miller and Moon, 1996; Cadigan and Nusse, 1997; Bienz and Clevers, 2000; Peifer and Polakis, 2000; Giles et al., 2003) . Upon Wnt stimulation, Dishevelled (Dsh) and frat-1 mediate the dissociation of GSK-3b and Axin (Li et al., 1999) . In addition, Axin is recruited to the cytoplasmic domain of the Wnt co-receptor LRP5/6 (Mao et al., 2001; Tolwinski et al., 2003; Tamai et al., 2004) . As a result, components of the Wnt multiprotein complex dissociate and b-catenin is stabilized. Accumulated b-catenin activates transcription of target genes through its interaction with T-cell factor/lymphoid enhancing factor (TCF/LEF) family of transcription factors (Miller and Moon, 1996; Cadigan and Nusse, 1997; Bienz and Clevers, 2000; Peifer and Polakis, 2000; Giles et al., 2003) . Importantly, mutations in GSK-3b phosphorylation sites of b-catenin result in unscheduled activation of the Wnt signaling pathway (Miller and Moon, 1996; Cadigan and Nusse, 1997; Bienz and Clevers, 2000; Peifer and Polakis, 2000; Giles et al., 2003) .
Ajuba is an LIM protein and has proline-rich SH3 recognition motifs in the N-terminal region, a nuclear export signal in the middle region and three LIM domains in the C-terminal region (Goyal et al., 1999) . LIM domains are characterized by two tandemly repeated zinc finger structures and are involved in many cellular events (Dawid et al., 1998) . Previous reports showed that Ajuba is involved in the regulation of cell proliferation and differentiation. Ajuba associates with Grb2, and its overexpression induces meiotic maturation of Xenopus oocytes in a manner dependent on Grb2 and Ras (Goyal et al., 1999) . Ajuba also induces endodermal differentiation of P19 embryonal carcinoma stem cells through activation of c-Jun kinase (Kanungo et al., 2000) . There are reports suggesting that b-catenin associates with the LIM protein FHL2 (four-and-a-half LIM-only protein 2) (Martin et al., 2002; Wei et al., 2003) . FHL2 colocalizes with b-catenin in the nucleus and enhances TCF/LEF-dependent transcription in various cell lines through the promotion of b-catenin acetylation by p300, which enhances the interaction between b-catenin and TCF4 (Martin et al., 2002; Wei et al., 2003; Labalette et al., 2004; Levy et al., 2004) . The data suggest that other LIM proteins may also be involved in the Wnt signaling pathway. In the present study, we investigated the role of Ajuba in the Wnt signaling pathway. We found that Ajuba associates with b-catenin and enhances GSK-3b-mediated phosphorylation of b-catenin. Our findings provide a novel insight in the regulation of the Wnt signaling pathway.
Results
Identification of Ajuba as a novel b-catenin-interacting protein We first investigated whether Ajuba associates with b-catenin. A pull-down assay with in vitro-translated b-catenin and glutathione S-transferase (GST)-Ajuba fusion protein purified from Escherichia coli showed that b-catenin was co-precipitated with GST-Ajuba but not with GST ( Figure 1a ). We next examined whether Ajuba and b-catenin interact with each other in a physiological condition. To detect endogenous Ajuba protein, we generated rabbit polyclonal antibodies against the N-terminal region of Ajuba. Immunoblot analysis of cell lysates revealed that the antibodies specifically recognized the 59-kDa endogenous Ajuba protein ( Figure 1b) . We then immunoprecipitated endogenous Ajuba with the antibodies. b-Catenin was detected in the Ajuba immunoprecipitates but not in control immunoglobulin precipitates (Figure 1c) . Similarly, Ajuba was detected in the b-catenin immunoprecipitates but not in control immunoglobulin precipitates (Figure 1c) . These results indicate that Ajuba associates directly with b-catenin in vivo.
Mapping of the interacting region of b-catenin and Ajuba To determine Ajuba-binding region within b-catenin, we constructed a series of deletion mutants of b-catenin (Figure 2a) . Co-immunoprecipitation analysis showed that Ajuba strongly interacted with armadillo repeats 7-9 (amino acids 400-530) of b-catenin (Figure 2a) . This region is different from the binding site of Wntregulating factors such as GSK-3b and Axin (Ikeda et al., 1998; Peifer and Polakis, 2000) , suggesting that the binding of Ajuba to b-catenin is not competitive with these molecules. Indeed co-immunoprecipitation assay using lysates of HEL293T cells transfected with b-catenin and Ajuba together with or without Axin showed that binding of Ajuba with b-catenin was not prevented by Axin (Supplementary Figure S3) . We also searched for the b-catenin-binding region within Ajuba. Co-immunoprecipitation analysis with various deletion mutants of Ajuba showed that all LIM domains together with the N-terminally flanking region (amino acids 232-538) of Ajuba was necessary for its binding to b-catenin (Figure 2b ). Like transcriptional cofactor FHL2 (Wei et al., 2003) , the LIM domains of Ajuba were important for the interaction with b-catenin, but the LIM domains alone were not sufficient for the interaction.
Suppression of b-catenin-TCF-dependent transcription by Ajuba To clarify the biological significance of the association between Ajuba and b-catenin, we exogenously expressed green fluorescent protein (GFP)-fused Ajuba (GFPAjuba) in HeLa cells and analysed the subcellular localization or level of endogenous b-catenin by immunofluorescence microscopy. We found that the expression levels of b-catenin were remarkably reduced in cells expressing GFP-Ajuba, but not in cells expressing GFP alone (Figure 3a) , suggesting that Ajuba promoted the degradation of b-catenin. The Ajubamediated decrease of b-catenin could result in inhibition of b-catenin-dependent gene expression. We then examined the effect of Ajuba on b-catenin-TCFmediated transcription using a luciferase reporter construct containing intact (TopFLASH) or mutated (FopFLASH) TCF-responsive elements. We transfected the reporter plasmid together with b-catenin and Ajuba expression plasmids into HEK293T cells. Whereas the reporter activity of TopFLASH was strongly activated by b-catenin, Ajuba suppressed b-catenin-TCF-activated transcription in a dose-dependent manner (Figure 3b ). The effect of Ajuba overexpression was also monitored by cyclin D1 expression that is one of the well-established Wnt target genes (Shtutman et al., 1999; Tetsu and McCormick, 1999) . Although cyclin D1 is activated by various transcription factors such as EtsB (Tetsu and McCormick, 1999) , Ajuba repressed b-catenin-activated cyclin D1 promoter, but not EtsBactivated cyclin D1 promoter (Figure 3c ). We also infected mouse fibroblast L cells with retroviruses that expressed GFP-Ajuba or GFP alone and prepared total RNA from the infected cells. Quantitative reverse transcription (RT)-PCR with cyclin D1 specific primers revealed that enforced expression of Ajuba suppressed expression of cyclin D1 mRNA (Figure 3d ). To further establish the role of Ajuba in the control of b-cateninmediated gene expression, we performed Ajuba depletion experiment. We used small interfering RNAs (siRNAs; Elbashir et al., 2001) to inhibit the expression of Ajuba. In Ajuba-depleted cells, b-catenin-TCFdependent transcription was activated as compared to that in control siRNA-transfected cells (Figure 3e ). In accordance with this, both b-catenin and cyclin D1 expression were increased in Ajuba-depleted cells (Figure 3e) . By flow cytometric analysis, we observed that population of cells in G 0 /G 1 phase was decreased and that of S and G 2 /M phase was increased in Ajubadepleted cells as compared to control cells ( Figure 3f ). Since cyclin D1 is a critical regulator for the progression of G 1 phase in the cell cycle (Quelle et al., 1993) , depletion of Ajuba resulted in stimulation of G 0 /G 1 to S phase progression in the cell cycle. These results suggested that Ajuba negatively regulates the b-catenin-TCF-mediated transcription and cell cycle progression.
Wnt stimulation induces destabilization of Ajuba
When we incubated L cells with Wnt-3A-conditioned medium (CM), we observed accumulation of b-catenin as reported previously (Shibamoto et al., 1998) (Figure 4a ). On the contrary, we found that the levels of Ajuba decreased after Wnt-3A stimulation ( Figure 4a ). Quantitative RT-PCR with Ajuba-specific primers revealed that mRNA levels of Ajuba did not change in the presence or the absence of Wnt-3A-CM (Figure 4b ), suggesting that the Ajuba is not regulated at the transcriptional level following Wnt-3A-CM stimulation. On the other hand, treatment of cells with proteasome inhibitor, MG132, inhibited the Wnt-3A-induced reduction of Ajuba (Figure 4c ), indicating that Ajuba is degraded through the ubiquitin-proteasome system. We also found that upon Wnt-3A stimulation, migration of Ajuba protein in sodium dodecyl sulfate polyacrylamide gel (SDS-PAGE) became faster in the presence of MG132 than its absence ( Figure 4c ). The data suggested that the fast-migrating form of Ajuba was more susceptible to proteasome-dependent degradation than the slow-migrating form. Since alkaline phosphatase treatment of the Ajuba-immunoprecipitates resulted in disappearance of the slow-migrating form of Ajuba (Figure 5a ), we concluded that the slow-migrating form of Ajuba was generated by phosphorylation and Wnt-3A stimulation promoted dephosphorylation of Ajuba.
To further investigate the molecular mechanism by which Wnt-3A stimulation promotes the Ajuba degradation, we examined whether GSK-3b phosphorylates Ajuba because Wnt stimulation inactivates GSK-3b (Miller and Moon, 1996; Cadigan and Nusse, 1997; Bienz and Clevers, 2000; Peifer and Polakis, 2000; Giles et al., 2003) . We performed in vitro kinase assay using recombinant Ajuba and GSK-3b. As shown in Figure 5b , Ajuba was phosphorylated by GSK-3b. We next examined the effect of LiCl, an inhibitor of GSK-3b, on Ajuba phosphorylation state and its stability. Treatment of cells with LiCl resulted in disappearance of phosphorylated form of Ajuba as well as the decreases the amount of Ajuba (Figure 5c ). These results indicated that GSK-3b-phosphorylated Ajuba is stable and Wnt stimulation-dependent inactivation of GSK-3b results in dephosphorylation and subsequent degradation of Ajuba.
Ajuba inhibits Wnt-activated gene transcription
We next examined the effect of Ajuba on Wnt-3A stimulation-dependent cellular response. When L cells were treated with Wnt-3A-CM, b-catenin remarkably accumulated both in the cytoplasm and in the nucleus (Shibamoto et al., 1998) . When GFP-Ajuba was exogenously expressed in L cells, b-catenin did not accumulate even after Wnt-3A-CM stimulation ( Figure 6 ). The accumulation of b-catenin was not suppressed by GFP expression (Figure 6 ). In contrast, depletion of Ajuba did not have any more effect on TopFLASH activity in the presence of Wnt-3A stimulation (Supplementary Figure S1) . Therefore, we assume that effect of Ajuba depletion is, at least in part, overlapping with that of Wnt stimulation. Taken together, we concluded that Ajuba inhibits the Wnt-stimulation-dependent cellular response.
Ajuba promotes GSK-3b-mediated b-catenin phosphorylation and b-catenin degradation Since the reduction of the b-catenin level is regulated through its phosphorylation by GSK-3b (Miller and Ajuba and b-catenin phosphorylation in the Wnt pathway K Haraguchi et al Moon, 1996; Cadigan and Nusse, 1997; Bienz and Clevers, 2000; Peifer and Polakis, 2000; Giles et al., 2003) , we examined the effect of Ajuba expression on GSK-3b-mediated b-catenin phosphorylation. In vitro kinase assay revealed that purified GSK-3b alone was unable to phosphorylate b-catenin efficiently (Figure 7a ). Interestingly, phosphorylation of b-catenin by GSK-3b was strongly enhanced by the addition of purified Ajuba protein (Figure 7a ). We also observed the direct interaction of Ajuba with b-catenin and GSK-3b ( Figure 1a, Supplementary Figure S2a ). These data suggested that Ajuba is responsible for GSK-3b-mediated phosphorylation of b-catenin by promoting interaction between b-catenin and GSK-3b. To confirm this, we exogenously expressed Ajuba in HEK293T cells and examined the phosphorylation state of b-catenin with antibodies recognizing phosphorylated b-catenin at Ser33, which is one of the phosphorylation sites by GSK-3b (Miller and Moon, 1996; Cadigan and Nusse, 1997; Bienz and Clevers, 2000; Peifer and Polakis, 2000; Giles et al., 2003) . As Ajuba expression increased, the levels of phosphorylated b-catenin increased, whereas overall b-catenin levels decreased (Figure 7b ). In Ajubadepleted cells, the level of b-catenin increased as compared to that in control siRNA-transfected cells (Figure 7c ). In addition, when the same amounts of b-catenin were immunoprecipitated from the lysates of both control and Ajuba-depleted cells, the degree of b-catenin phosphorylation was reduced in Ajuba-depleted cells (Figure 7c ). We further examined the effect of Ajuba on TCF-dependent reporter activity enhanced by the b-catenin mutant in which Serine37 is substituted with Alanine (S37A b-catenin). S37A b-catenin is resistant to proteasome-dependent degradation in comparison with wild-type b-catenin because phosphorylation of b-catenin by GSK-3b was insufficient (Filali et al., 2002) . We transfected wild-type or S37A b-catenin expression plasmid into HEK293T cells together with TopFLASH reporter plasmid to activate the reporter at the same extent. Ajuba effectively suppressed the wildtype b-catenin-induced, but not S37A b-catenin-induced TopFLASH activity (Figure 7d ). To confirm that Ajuba promotes GSK-3b-mediated phosphorylation and subsequent degradation of b-catenin, we transfected Ajuba and b-catenin phosphorylation in the Wnt pathway K Haraguchi et al FLAG-Ajuba expression plasmid together with Mycb-catenin and HA-GSK-3b expression plasmids into HeLa cells. Co-immunoprecipitation analysis revealed that the interaction between b-catenin and GSK-3b was strongly enhanced by expression of Ajuba (Figure 7e ). Taken together, these data suggest that Ajuba facilitates GSK-3b-mediated phosphorylation and degradation of b-catenin by strengthening the association between b-catenin and GSK-3b.
Discussion
In the present study, we found that Ajuba was a novel b-catenin-binding protein.
The interaction between Ajuba and b-catenin resulted in the promotion of GSK-3b-mediated phosphorylation of b-catenin and its subsequent degradation. Using a series of deletion mutants, we found that similar to another LIM protein FHL2 (Wei et al., 2003) , LIM domains of Ajuba were necessary for the binding to b-catenin (Figure 2b ). We also showed that armadillo repeats 7-9 in b-catenin participated in the association with Ajuba (Figure 2a ). To date, many factors have been identified to be important for the regulation of the Wnt signaling (Miller and Moon, 1996; Cadigan and Nusse, 1997; Bienz and Clevers, 2000; Peifer and Polakis, 2000; Giles et al., 2003) . One of them, Axin, facilitates GSK3b-dependent phosphorylation of b-catenin by forming a complex with these molecules (Ikeda et al., 1998) . Since the Ajuba-binding region in b-catenin is different from the Axin-binding region in b-catenin (Ikeda et al., 1998) and Axin did not prevent Ajuba from binding to b-catenin (Supplementary Figure S3) , Ajuba might cooperate with Axin in b-catenin phosphorylation by forming a multi-protein complex. Indeed, we observed that Ajuba interacted with both b-catenin and GSK-3b through different regions, and that Axin was included in the anti-Ajuba immunoprecipitates (Figure 1a , Supplementary Figures S2 and S3) .
We found that exogenous expression of Ajuba suppressed b-catenin-TCF-dependent transcriptional activation and expression of cyclin D1 gene ( Figure  3c -e). Cyclin D1 is one of the representative Wnt target genes, which is responsible for Wnt-dependent cell growth regulation (Shtutman et al., 1999; Tetsu and McCormick, 1999) . By flow cytometric analysis, we observed that population of cells in G 0 /G 1 phase was decreased and that of cells in S phase was increased in the absence of Ajuba (Figure 3e ). These data suggested that Ajuba is involved in cell growth regulation by inhibiting the Wnt signaling pathway. Ajuba is expressed in embryonal cells and its expression increases during endodermal differentiation (Kanungo et al., 2000) . In mouse tissues, Ajuba expresses ubiquitously in early embryonic stage and its expression becomes restricted to skin, uterus, kidney, brain (post-E12.5) as development is progressed (Goyal et al., 1999) . Thus, we hypothesize that Ajuba may function in prematuring embryo and be involved in cell differentiation by regulating the Wnt signaling pathway. Although Ajubanull mice showed no obvious defect in development (Pratt et al., 2005) , it is possible that other proteins such as Axin could compensate for the function of Ajuba in developmental stage.
Wnt-3A stimulation stabilized b-catenin by inhibiting GSK-3b (Miller and Moon, 1996; Cadigan and Nusse, 1997; Bienz and Clevers, 2000; Peifer and Polakis, 2000; Giles et al., 2003) . In present data, we found that Ajuba was dephosphorylated and subsequently degraded through proteasome-dependent system after Wnt-3A stimulation (Figure 4 ). The data suggested that both activation of b-catenin and inactivation of Ajuba are important in the Wnt signaling pathway. Indeed, enforced expression of Ajuba inhibited the Wnt-3A-induced activation of b-catenin (Figure 6 ), whereas depletion of Ajuba activated b-catenin-TCF reporter activity (Figure 3e ). It should be noted that depletion of Ajuba did not induce further the activation of Wnt-induced reporter activity in the presence of Wnt stimulation (Supplementary Figure S1) . In this case, depletion of Ajuba might have little additional effect on the Wnt signaling due to degradation of Ajuba (Figures  4a and c) .
Because Ajuba shuttles between the nucleus and the cytoplasm, and because we detected endogenous Ajuba both in the cytoplasm and the nucleus (Supplementary Figure S4 ; Kanungo et al., 2000) , Ajuba might be involved in the transport of b-catenin from the nucleus to the cytoplasm, where b-catenin undergoes phosphorylation and degradation. Thus, not only cytoplasmic but also nuclear b-catenin levels might have decreased in Ajuba-overexpressed cells (Figures 3a and 6 ). Further studies are necessary to elucidate the mechanisms by which Ajuba transports b-catenin.
Mutations of the Wnt pathway components such as APC, Axin and b-catenin were discovered in various types of tumors. Mutations in these genes are linked to inactivation of APC and Axin, or unscheduled activation of b-catenin (Miller and Moon, 1996; Cadigan and Nusse, 1997; Bienz and Clevers, 2000; Peifer and Polakis, 2000; Giles et al., 2003) . Abnormal expression of the Wnt signaling components is also related to tumorigenesis. For instance, b-catenin-binding protein B9L, an activator of b-catenin-TCF-mediated transcription, was highly expressed in colorectal tumors (Adachi et al., 2004) . Moreover, enhanced expression of LIM protein FHL2 was detected in hepatoblastoma cancer cells (Wei et al., 2003) . Search for mutation or deregulation of Ajuba in tumors would be important in obtaining valuable insights into the mechanism of cancer development.
Materials and methods
Cell culture HEK293T, HeLa, L and Plat-E cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (Nissui, Tokyo, Japan) supplemented with 10% (v/v) fetal bovine serum (FBS). Control or Wnt-3A-CM was prepared from L or L-Wnt-3A cells following American Type Culture Collection's (Manassas, VA, USA) protocol.
Antibodies
Polyclonal antibodies against Ajuba were prepared by immunizing rabbit with peptides containing amino acids 1-110 of Ajuba. Antibodies were purified by affinity chromatography. Monoclonal antibodies against b-catenin (BD, NJ, USA), a-tubulin (Sigma, St Louis, MO, USA), cyclin D1 (sc-450, Santa Cruz Biotechnology, CA, USA), FLAG (M2, Sigma), Myc (sc-40, Santa Cruz Biotechnology) and HA (Cell Signaling, Beverly, MA, USA), and polyclonal antibodies against FLAG (F.7425, Sigma), phosphorylated b-catenin (Ser 33) (sc-16743-R, Santa Cruz Biotechnology) and GFP (MBL, Nagoya, Japan) were also used.
In vitro pull-down assay b-Catenin was synthesized with the TNT-Coupled Reticulocyte Lysate System (Promega, Tokyo, Japan). In vitrotranslated b-catenin and GST or GST-Ajuba purified from E. coli was incubated in buffer A (50 mM Tris-HCl, pH 7.4, 0.5% Triton X-100, 10% glycerol, 20 mM KCl, 2 mM MgCl 2 , 0.1 mM CaCl 2 ) for 1 h at 41C. The protein complex was adsorbed to glutathione-Sepharose (Amersham Pharmacia Biotech, Little Chalfont, Buchinghamshire, UK) for 1 h at 41C. After the sepharose was washed with buffer A, samples were resolved by 10% SDS-PAGE.
Immunoprecipitation assay
Cells were lysed in buffer B (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM ethylenediamine tetraacetic acid (EDTA), pH 7.5, 2 mM Na 3 VO 4 , 10 mM NaF, 0.1 mM phenylmethylsulphonyl fluoride (PMSF)) containing 1% Triton X-100. Lysates were incubated with antibodies for 1 h at 41C. Immunocomplexes were adsorbed to protein G Sepharose 4B (Amersham Pharmacia Biotech) for 1 h at 41C. After the sepharose was washed with buffer B containing 0.1% Triton X-100, samples were resolved by SDS-PAGE.
In vitro kinase assay Kinase reactions were carried out at 301C for 10 min in buffer C (50 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 , 1 mM dithiothreitol (DTT), 20 mM ATP) containing 10 mCi [g-32 P] ATP (Amersham Pharmacia Biotech). Samples were resolved by SDS-PAGE and autoradiography.
RNAi
Small interfering RNAs were transfected with oligofectamine (Invitrogen Japan, Tokyo, Japan). Target sequences were Ajuba 1, 5 0 -GGACCGGGAUUAUCACUUUTT-3 0 and Ajuba 2, 5 0 -CCA AGUAUACUGUGUCACCTT-3 0 . Control siRNAs were from Euglena gracilis chloroplast DNA and target sequence was control 5 0 -UUCUCCGAACGUGUCACGUTT-3 0 .
Luciferase assay Experiments were performed with a Dual-Luciferase Assay System (Promega) as previously described (Tago et al., 2000) . All data are presented as the mean7s.d. of triplicate samples.
Retroviral infection
Retroviral vector was transiently transfected into Plat-E packaging cells with Lipofectamine Plus (Invitrogen Japan). After 24 h, cells were changed into a fresh medium and after an additional 24 h, the culture medium was collected and centrifuged at 2000 g for 30 min. The supernatant with 10 mg/ ml polybrene (Sigma) was added to L cells. The infected cells were selected by 2 mg/ml puromycin (Sigma) for 3 days.
RT-PCR with real-time quantification Cells were suspended in ISOGEN (Nippon Gene, Tokyo, Japan) and total RNA was isolated. Reverse transcription was performed with oligo-dT primer and reverse transcriptase Superscript II (Invitrogen) to generate cDNA. Quantitative real-time PCR was carried out with SYBR Premix Ex Taq (Takara, Kyoto, Japan) and the indicated primers. Primer sequences are cyclin D1-FW, 5 0 -AAGGAGATTGTGCC ATCCAT-3 0 ; cyclin D1-RV, 5 0 -GCACTTCTGCTCCTCAC AGA-3 0 ; Ajuba-FW, 5 0 -TGGCTCTGTCTACTGTGAGG AA-3 0 ; Ajuba-RV, 5 0 -GCCACAGACACAGCACTTCT-3 0 ; HPRT-FW, 5 0 -GTAATGATCAGTCAACGGGGGAC-3 0 ; and HPRT-RV, 5 0 -CCAGCAAGCTTGCAACCTTAACCA-3 0 .
Abbreviations APC, adenomatous polyposis coli; GFP, green fluorescent protein; GSK-3b, glycogen synthase kinase-3b; GST, glutathione S-transferase; HA, hemagglutinin; LEF, lymphoid enhancing factor; PBS, phosphate-buffered saline; TCF, T-cell factor.
